Chris Lemos's questions to Capricor Therapeutics Inc (CAPR) leadership • Q2 2025
Question
Chris Lemos began to ask a question about who the company would be dealing with at the Type A meeting before the line was disconnected.
Answer
CEO Linda Marbán acknowledged that the question was cut off due to a technical issue and proceeded to deliver her closing remarks for the conference call.